JP2008531479A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531479A5 JP2008531479A5 JP2007553252A JP2007553252A JP2008531479A5 JP 2008531479 A5 JP2008531479 A5 JP 2008531479A5 JP 2007553252 A JP2007553252 A JP 2007553252A JP 2007553252 A JP2007553252 A JP 2007553252A JP 2008531479 A5 JP2008531479 A5 JP 2008531479A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- chloro
- amino
- group
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 15
- -1 N-chloroaminoethylphosphonic acid diester Chemical class 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 8
- VAUDXPRANUFYEC-UHFFFAOYSA-N 2-(chloroamino)-5-phosphonopentanoic acid Chemical compound OC(=O)C(NCl)CCCP(O)(O)=O VAUDXPRANUFYEC-UHFFFAOYSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 4
- DQSLXKNCNPPTSN-UHFFFAOYSA-N 1-(chloroamino)propylphosphonic acid Chemical compound CCC(NCl)P(O)(O)=O DQSLXKNCNPPTSN-UHFFFAOYSA-N 0.000 claims description 3
- XIGJZYVHLIRSFU-UHFFFAOYSA-N 2-(bromoamino)-5-phosphonopentanoic acid Chemical compound OC(=O)C(NBr)CCCP(O)(O)=O XIGJZYVHLIRSFU-UHFFFAOYSA-N 0.000 claims description 3
- KBINJLBTMJFAPH-UHFFFAOYSA-N 2-(chloroamino)-2-methylpropane-1-sulfonic acid Chemical compound ClNC(C)(C)CS(O)(=O)=O KBINJLBTMJFAPH-UHFFFAOYSA-N 0.000 claims description 3
- SCFWQPHRDQRQIW-UHFFFAOYSA-N 2-(chloroamino)-8-phosphonooctanoic acid Chemical compound OC(=O)C(NCl)CCCCCCP(O)(O)=O SCFWQPHRDQRQIW-UHFFFAOYSA-N 0.000 claims description 3
- BASCKKRUKJKATL-UHFFFAOYSA-N CC(C)C(NCl)P(O)(O)=O Chemical compound CC(C)C(NCl)P(O)(O)=O BASCKKRUKJKATL-UHFFFAOYSA-N 0.000 claims description 3
- DARKVQOMVNRQNZ-JEDNCBNOSA-N OBO.CC(C)C[C@H](NCl)C(O)=O Chemical compound OBO.CC(C)C[C@H](NCl)C(O)=O DARKVQOMVNRQNZ-JEDNCBNOSA-N 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- BCRSJKZAODSYFK-UHFFFAOYSA-N 2-(chloroamino)-3-phosphonopropanoic acid Chemical compound OC(=O)C(NCl)CP(O)(O)=O BCRSJKZAODSYFK-UHFFFAOYSA-N 0.000 claims description 2
- IPWWLXWYFSGQFM-UHFFFAOYSA-N 2-(chloroamino)propane-1-sulfonic acid Chemical compound ClNC(C)CS(O)(=O)=O IPWWLXWYFSGQFM-UHFFFAOYSA-N 0.000 claims description 2
- GDVDLFHXJBBZOE-UHFFFAOYSA-N 3-(chloroamino)-2,2,3-trimethylbutanoic acid Chemical compound ClNC(C)(C)C(C)(C)C(O)=O GDVDLFHXJBBZOE-UHFFFAOYSA-N 0.000 claims description 2
- CEWZMYBSKUHYMS-UHFFFAOYSA-N 4-(chloroamino)-4-phosphonobutanoic acid Chemical compound OC(=O)CCC(NCl)P(O)(O)=O CEWZMYBSKUHYMS-UHFFFAOYSA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 239000004599 antimicrobial Substances 0.000 claims 4
- 150000001721 carbon Chemical group 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 229940121375 antifungal agent Drugs 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 244000052769 pathogen Species 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 206010052428 Wound Diseases 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 229960005475 antiinfective agent Drugs 0.000 claims 2
- 239000003443 antiviral agent Substances 0.000 claims 2
- 239000003899 bactericide agent Substances 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001589 carboacyl group Chemical group 0.000 claims 2
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical group C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 claims 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000002993 cycloalkylene group Chemical group 0.000 claims 2
- 238000005202 decontamination Methods 0.000 claims 2
- 230000003588 decontaminative effect Effects 0.000 claims 2
- 239000000645 desinfectant Substances 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000002346 iodo group Chemical group I* 0.000 claims 2
- 230000007774 longterm Effects 0.000 claims 2
- 230000003330 sporicidal effect Effects 0.000 claims 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 230000017423 tissue regeneration Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
- QYNRGGHZWCUZLK-UHFFFAOYSA-N 2-(dichloroamino)-2-methylpropane-1-sulfonic acid Chemical compound ClN(Cl)C(C)(C)CS(O)(=O)=O QYNRGGHZWCUZLK-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- DRNNATGSBCVJBN-UHFFFAOYSA-N 2-amino-2-methylpropane-1-sulfonic acid Chemical compound CC(C)(N)CS(O)(=O)=O DRNNATGSBCVJBN-UHFFFAOYSA-N 0.000 description 5
- VOROEQBFPPIACJ-UHFFFAOYSA-N 5-Phosphononorvaline Chemical compound OC(=O)C(N)CCCP(O)(O)=O VOROEQBFPPIACJ-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- COIDHHVBAVTJFV-UHFFFAOYSA-N 2-(dichloroamino)-5-phosphonopentanoic acid Chemical compound OC(=O)C(N(Cl)Cl)CCCP(O)(O)=O COIDHHVBAVTJFV-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 229940000635 beta-alanine Drugs 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- DGSLPJDIFKVSIB-UHFFFAOYSA-N (1-azaniumyl-2-methylpropyl)-hydroxyphosphinate Chemical compound CC(C)C(N)P(O)(O)=O DGSLPJDIFKVSIB-UHFFFAOYSA-N 0.000 description 2
- YIBKSASUZFBMOU-UHFFFAOYSA-N 1-(dichloroamino)propane-2-sulfonic acid Chemical compound OS(=O)(=O)C(C)CN(Cl)Cl YIBKSASUZFBMOU-UHFFFAOYSA-N 0.000 description 2
- DELJNDWGTWHHFA-UHFFFAOYSA-N 1-azaniumylpropyl(hydroxy)phosphinate Chemical compound CCC(N)P(O)(O)=O DELJNDWGTWHHFA-UHFFFAOYSA-N 0.000 description 2
- BAUYKXPDNLWGGL-UHFFFAOYSA-N 2-(chloroamino)propan-2-ylphosphonic acid Chemical compound ClNC(C)(C)P(O)(O)=O BAUYKXPDNLWGGL-UHFFFAOYSA-N 0.000 description 2
- JJQITYDTBUXIDS-UHFFFAOYSA-N 2-(dibromoamino)-2-methylpropane-1-sulfonic acid Chemical compound BrN(Br)C(C)(C)CS(O)(=O)=O JJQITYDTBUXIDS-UHFFFAOYSA-N 0.000 description 2
- IHEFYJCAHPMNNZ-UHFFFAOYSA-N 2-(dichloroamino)-8-phosphonooctanoic acid Chemical compound OC(=O)C(N(Cl)Cl)CCCCCCP(O)(O)=O IHEFYJCAHPMNNZ-UHFFFAOYSA-N 0.000 description 2
- LDSLVJUAHMPZBB-UHFFFAOYSA-N 2-(diiodoamino)ethanesulfonic acid Chemical compound OS(=O)(=O)CCN(I)I LDSLVJUAHMPZBB-UHFFFAOYSA-N 0.000 description 2
- XUGMGYUIGNYMJQ-UHFFFAOYSA-N 2-(iodoamino)ethanesulfonic acid Chemical compound OS(=O)(=O)CCNI XUGMGYUIGNYMJQ-UHFFFAOYSA-N 0.000 description 2
- IAZCXYBRDWVPNV-UHFFFAOYSA-N 2-amino-3-methyl-3-sulfobutanoic acid Chemical compound OS(=O)(=O)C(C)(C)C(N)C(O)=O IAZCXYBRDWVPNV-UHFFFAOYSA-N 0.000 description 2
- LBTABPSJONFLPO-UHFFFAOYSA-N 2-amino-3-phosphonopropanoic acid Chemical compound OC(=O)C(N)CP(O)(O)=O LBTABPSJONFLPO-UHFFFAOYSA-N 0.000 description 2
- DYGRPJWAYXRMQZ-UHFFFAOYSA-N 2-aminopropan-2-ylphosphonic acid Chemical compound CC(C)(N)P(O)(O)=O DYGRPJWAYXRMQZ-UHFFFAOYSA-N 0.000 description 2
- NETIXPOFUYPXNI-UHFFFAOYSA-N 2-aminopropane-2-sulfonic acid Chemical compound CC(C)(N)S(O)(=O)=O NETIXPOFUYPXNI-UHFFFAOYSA-N 0.000 description 2
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 2
- OXIWSCWSIBBUDO-UHFFFAOYSA-N 3-(dichloroamino)-2,2,3-trimethylbutanoic acid Chemical compound ClN(Cl)C(C)(C)C(C)(C)C(O)=O OXIWSCWSIBBUDO-UHFFFAOYSA-N 0.000 description 2
- SNKZJIOFVMKAOJ-UHFFFAOYSA-N 3-Aminopropanesulfonate Chemical compound NCCCS(O)(=O)=O SNKZJIOFVMKAOJ-UHFFFAOYSA-N 0.000 description 2
- DWYLYZGWBIVRGV-UHFFFAOYSA-N 4-(dichloroamino)-4-phosphonobutanoic acid Chemical compound OC(=O)CCC(N(Cl)Cl)P(O)(O)=O DWYLYZGWBIVRGV-UHFFFAOYSA-N 0.000 description 2
- SODXFOVXZATGPJ-UHFFFAOYSA-N 4-amino-4-phosphonobutanoic acid Chemical compound OP(=O)(O)C(N)CCC(O)=O SODXFOVXZATGPJ-UHFFFAOYSA-N 0.000 description 2
- OPIXQPCOZBIRMY-UHFFFAOYSA-N CC(C)CC(N)(C(O)=O)P(O)(O)=O Chemical compound CC(C)CC(N)(C(O)=O)P(O)(O)=O OPIXQPCOZBIRMY-UHFFFAOYSA-N 0.000 description 2
- 241001135569 Human adenovirus 5 Species 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- YKTCVYHHAFHLHL-JEDNCBNOSA-N OBO.CC(C)C[C@H](N(Cl)Cl)C(O)=O Chemical compound OBO.CC(C)C[C@H](N(Cl)Cl)C(O)=O YKTCVYHHAFHLHL-JEDNCBNOSA-N 0.000 description 2
- KXCDENIMXRKIPT-UHFFFAOYSA-N OBO.OC(=O)CCNCl Chemical compound OBO.OC(=O)CCNCl KXCDENIMXRKIPT-UHFFFAOYSA-N 0.000 description 2
- GBUDGXDEROGHBY-JEDNCBNOSA-N OP(O)=O.CC(C)C[C@H](N(Cl)Cl)C(O)=O Chemical compound OP(O)=O.CC(C)C[C@H](N(Cl)Cl)C(O)=O GBUDGXDEROGHBY-JEDNCBNOSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- LDCBEAIUZPYSBX-JEDNCBNOSA-N P(O)(O)=O.ClN[C@@H](CC(C)C)C(=O)O Chemical compound P(O)(O)=O.ClN[C@@H](CC(C)C)C(=O)O LDCBEAIUZPYSBX-JEDNCBNOSA-N 0.000 description 2
- UEQTVRUQHVQHSW-UHFFFAOYSA-N [1-(dichloroamino)-2-methylpropyl]phosphonic acid Chemical compound CC(C)C(N(Cl)Cl)P(O)(O)=O UEQTVRUQHVQHSW-UHFFFAOYSA-N 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000013580 millipore water Substances 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- MEGHVKHOSRPKFB-REOHCLBHSA-N (2s)-2-(dichloroamino)propanoic acid Chemical compound ClN(Cl)[C@@H](C)C(O)=O MEGHVKHOSRPKFB-REOHCLBHSA-N 0.000 description 1
- QUOIXMXPWCACSF-UHFFFAOYSA-N 1-(dichloroamino)propylphosphonic acid Chemical compound CCC(N(Cl)Cl)P(O)(O)=O QUOIXMXPWCACSF-UHFFFAOYSA-N 0.000 description 1
- ZFJWYAYBWZHPGT-UHFFFAOYSA-N 1-amino-2-methylpropane-2-sulfonic acid Chemical compound NCC(C)(C)S(O)(=O)=O ZFJWYAYBWZHPGT-UHFFFAOYSA-N 0.000 description 1
- GBYFFQSMDBOMCX-UHFFFAOYSA-N 2-(dibromoamino)-5-phosphonopentanoic acid Chemical compound OC(=O)C(N(Br)Br)CCCP(O)(O)=O GBYFFQSMDBOMCX-UHFFFAOYSA-N 0.000 description 1
- YDRDBSJEDQYEFJ-UHFFFAOYSA-N 2-(dichloroamino)-3-phosphonopropanoic acid Chemical compound OC(=O)C(N(Cl)Cl)CP(O)(O)=O YDRDBSJEDQYEFJ-UHFFFAOYSA-N 0.000 description 1
- FWACYDHVHFBQHS-UHFFFAOYSA-N 2-(dichloroamino)propan-2-ylphosphonic acid Chemical compound ClN(Cl)C(C)(C)P(O)(O)=O FWACYDHVHFBQHS-UHFFFAOYSA-N 0.000 description 1
- WYRXPDKKQWTPKX-UHFFFAOYSA-N 2-(dichloroamino)propane-1-sulfonic acid Chemical compound ClN(Cl)C(C)CS(O)(=O)=O WYRXPDKKQWTPKX-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- KGGCRFYWXLVUQQ-UHFFFAOYSA-N 2-amino-8-phosphonooctanoic acid Chemical compound OC(=O)C(N)CCCCCCP(O)(O)=O KGGCRFYWXLVUQQ-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- YFXICVBBMRYJMK-UHFFFAOYSA-N OBO.NCCC(O)=O Chemical compound OBO.NCCC(O)=O YFXICVBBMRYJMK-UHFFFAOYSA-N 0.000 description 1
- DXDZUCBULNMIIX-UHFFFAOYSA-N OBO.OC(=O)CCN(Cl)Cl Chemical compound OBO.OC(=O)CCN(Cl)Cl DXDZUCBULNMIIX-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- BMGMQYRPZOGZFU-YFKPBYRVSA-N [(1r)-1-amino-3-methylbutyl]boronic acid Chemical compound CC(C)C[C@H](N)B(O)O BMGMQYRPZOGZFU-YFKPBYRVSA-N 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical class C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- 229960000308 fosfomycin Drugs 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64736605P | 2005-01-25 | 2005-01-25 | |
| US60/647,366 | 2005-01-25 | ||
| PCT/US2006/002875 WO2006081392A1 (en) | 2005-01-25 | 2006-01-25 | N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008531479A JP2008531479A (ja) | 2008-08-14 |
| JP2008531479A5 true JP2008531479A5 (enExample) | 2009-03-05 |
| JP5329095B2 JP5329095B2 (ja) | 2013-10-30 |
Family
ID=36441417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007553252A Expired - Fee Related JP5329095B2 (ja) | 2005-01-25 | 2006-01-25 | 次亜ハロゲン酸と組み合わせる、ｎ−ハロゲン化アミノ酸およびｎ，ｎ−ジハロゲン化アミノ酸 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7846971B2 (enExample) |
| EP (1) | EP1896001B1 (enExample) |
| JP (1) | JP5329095B2 (enExample) |
| KR (1) | KR20070098947A (enExample) |
| CN (1) | CN101132785A (enExample) |
| AU (1) | AU2006208046B2 (enExample) |
| BR (1) | BRPI0607302A2 (enExample) |
| CA (1) | CA2595889C (enExample) |
| ES (1) | ES2421157T3 (enExample) |
| IL (1) | IL184771A (enExample) |
| MX (1) | MX2007008928A (enExample) |
| TW (1) | TWI386201B (enExample) |
| WO (1) | WO2006081392A1 (enExample) |
| ZA (1) | ZA200706402B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4994033B2 (ja) * | 2003-08-18 | 2012-08-08 | ノバベイ・ファーマシューティカルズ・インコーポレイテッド | Ｎ，ｎ−ジハロゲン化アミノ酸および誘導体 |
| US8747882B2 (en) | 2005-04-21 | 2014-06-10 | Astra Tech Ab | Catheter assembly with bactericidal effect |
| JP2009517335A (ja) * | 2005-09-21 | 2009-04-30 | ノバベイ・ファーマシューティカルズ・インコーポレイテッド | 次亜ハロゲン酸組成物を用いた尿路感染（ｕｔｉ）を含む細菌・菌類感染の防止及び処理のためのシステム及び方法 |
| CA2624677A1 (en) * | 2005-10-06 | 2007-04-19 | Novacal Pharmaceuticals, Inc. | System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids |
| TW200843787A (en) * | 2006-12-29 | 2008-11-16 | Novabay Pharmaceuticals Inc | N-halogenated amino compounds and derivatives; compositions and methods of using them |
| US20080288019A1 (en) * | 2007-01-31 | 2008-11-20 | Adam Heller | Electrochemical management of pain |
| UY31059A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado |
| UY31058A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios |
| UY31056A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Fromulaciones aminocido n-halogenado y metodos de limpieza y desinfeccion |
| UY31057A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado que contiene acido alifatico |
| UY31055A1 (es) * | 2008-02-01 | 2008-10-31 | Alcon Res Ltd | Sales antimicrobianas de aminoacido n-halogenado |
| EP2265267B1 (en) * | 2008-04-10 | 2016-09-21 | Waldemar Gottardi | Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections |
| US20110091570A1 (en) * | 2008-04-15 | 2011-04-21 | Waldemar Gottardi | Compositions and Devices for Antisepsis and Anticoagulation |
| IL192262A (en) * | 2008-06-17 | 2016-05-31 | Z H T Eng Equipment And Tech Ltd | A polymer that releases drugs into the animal body, a medicinal product containing it and a method for its preparation |
| WO2010017405A1 (en) * | 2008-08-06 | 2010-02-11 | Adam Heller | Methods and compositions for the treatment of pain |
| NZ590878A (en) * | 2008-08-12 | 2013-01-25 | Novabay Pharmaceuticals Inc | Antimicrobial gel formulations comprising an halogenated amine compound dispersed in a poly(acrylic acid) water-swellable polymer |
| US8764638B2 (en) | 2008-10-17 | 2014-07-01 | Al Medical Devices, Inc. | Endotracheal intubation device |
| EP2341777B1 (en) * | 2008-11-07 | 2015-01-21 | NovaBay Pharmaceuticals, Inc. | Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions |
| EP2341886B1 (en) | 2008-11-07 | 2015-08-26 | NovaBay Pharmaceuticals, Inc. | Antimicrobial n-chlorinated compositions |
| WO2010091280A1 (en) | 2009-02-06 | 2010-08-12 | Alcon Research, Ltd. | N-halogenated amino acid formulations comprising phosphine or amine oxides |
| MX2011009709A (es) * | 2009-03-18 | 2011-12-06 | Olatec Ind Llc | Compuestos para el tratamiento de la inflamacion y del dolor. |
| US20100272783A1 (en) * | 2009-04-24 | 2010-10-28 | Novabay Pharmaceuticals, Inc. | Methods of Treating Infections of the Nail |
| WO2011014460A1 (en) * | 2009-07-27 | 2011-02-03 | Novabay Pharmaceuticals, Inc. | Methods of treating infections of the nail or skin using hypohalite |
| CA2787461A1 (en) * | 2010-02-04 | 2011-08-11 | Novabay Pharmaceuticals, Inc. | Polysaccharide based antimicrobial formulations |
| US9888832B2 (en) | 2010-09-24 | 2018-02-13 | Blink Device LLC | Endotracheal intubation device |
| TWI407907B (zh) | 2010-10-04 | 2013-09-11 | Far Eastern New Century Corp | An antibacterial agent with water solubility and biodegradability |
| WO2012172071A2 (en) | 2011-06-15 | 2012-12-20 | Orasolv Ab | Detection and removal of carious dentin tissue. |
| SE536581C2 (sv) | 2012-07-24 | 2014-03-11 | Rls Global Ab | Ett kit för behandling av sår eller liknande och ett preparat och metoder därav |
| MX2018015233A (es) | 2016-06-09 | 2019-05-06 | Johnson Matthey Plc | Produccion electrolitica de soluciones de cloramina organica. |
| BR112020015444A2 (pt) * | 2018-01-30 | 2020-12-08 | Buckman Laboratories International, Inc | Método para controlar o crescimento de pelo menos um microrganismo em um produto, método para controlar o crescimento de pelo menos um microrganismo contaminante em um estoque de abastecimento contendo carboidrato fermentável, método para produzir etanol por fermentação com crescimento controlado de microrganismos contaminantes e solução aquosa |
| CN113729039A (zh) * | 2021-08-27 | 2021-12-03 | 上海罗克环控节能科技股份有限公司 | 一种绿色环保消毒液及其制造方法 |
| US12251486B2 (en) | 2021-09-09 | 2025-03-18 | Toyota Motor North America, Inc. | Vehicle sanitizing systems and methods for using the same |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3998945A (en) * | 1972-06-12 | 1976-12-21 | National Patent Development Corporation | Dental treatment |
| US4015008A (en) * | 1974-02-01 | 1977-03-29 | National Patent Development Corporation | N,N-dichloro substituted aminocarboxylic acids as microbiocides |
| US3950536A (en) * | 1974-02-01 | 1976-04-13 | Sol Joseph Barer | N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides |
| US4045578A (en) * | 1974-06-14 | 1977-08-30 | Interx Research Corporation | N-chloro-amino acid derivatives exhibiting antibacterial activity |
| US3966796A (en) * | 1974-06-14 | 1976-06-29 | Interx Research Corporation | N-chloro-amino acid derivatives activity |
| US4386103A (en) * | 1981-01-30 | 1983-05-31 | Merck & Co., Inc. | Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents |
| US5096700A (en) * | 1990-09-28 | 1992-03-17 | The Procter & Gamble Company | Halogenated aminohexanoates and aminobutyrates antimicrobial agents |
| DE4041703C2 (de) * | 1990-12-24 | 1993-10-21 | Waldemar Dr Gottardi | Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung |
| JP3759757B2 (ja) * | 1994-01-13 | 2006-03-29 | 相互薬工株式会社 | 殺菌剤 |
| US5753701A (en) * | 1996-10-25 | 1998-05-19 | University Of Kentucky | N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection |
| DE19712565A1 (de) * | 1997-03-25 | 1998-10-01 | Thomas W Dr Stief | Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes |
| DE19816102C1 (de) * | 1998-04-10 | 1999-09-16 | Waldemar Gottardi | Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen |
| CA2320556A1 (en) | 1999-09-29 | 2001-03-29 | Queen's University At Kingston | N,n-dichlorinated omega amino acids and uses thereof |
| WO2002022118A1 (de) | 2000-09-14 | 2002-03-21 | Waldemar Gottardi | Fungizides mittel enthaltend n-chlortaurin sowie dessen verwendung |
| FR2819723B1 (fr) * | 2001-01-23 | 2006-11-17 | Arnaud Mainnemare | Composition halogene, son procede de preparation et ses utilisations |
| US20040002871A1 (en) * | 2002-06-27 | 2004-01-01 | Geranio Nicholas L. | Integrated property database and search engine |
| JP4994033B2 (ja) * | 2003-08-18 | 2012-08-08 | ノバベイ・ファーマシューティカルズ・インコーポレイテッド | Ｎ，ｎ−ジハロゲン化アミノ酸および誘導体 |
| JP2007514782A (ja) * | 2003-12-17 | 2007-06-07 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法 |
| TW200843787A (en) | 2006-12-29 | 2008-11-16 | Novabay Pharmaceuticals Inc | N-halogenated amino compounds and derivatives; compositions and methods of using them |
-
2006
- 2006-01-24 TW TW095102567A patent/TWI386201B/zh not_active IP Right Cessation
- 2006-01-25 ES ES06733945T patent/ES2421157T3/es not_active Expired - Lifetime
- 2006-01-25 JP JP2007553252A patent/JP5329095B2/ja not_active Expired - Fee Related
- 2006-01-25 US US11/339,987 patent/US7846971B2/en active Active
- 2006-01-25 MX MX2007008928A patent/MX2007008928A/es active IP Right Grant
- 2006-01-25 AU AU2006208046A patent/AU2006208046B2/en not_active Ceased
- 2006-01-25 CA CA2595889A patent/CA2595889C/en not_active Expired - Fee Related
- 2006-01-25 KR KR1020077019438A patent/KR20070098947A/ko not_active Ceased
- 2006-01-25 BR BRPI0607302-6A patent/BRPI0607302A2/pt not_active Application Discontinuation
- 2006-01-25 EP EP06733945.7A patent/EP1896001B1/en not_active Expired - Lifetime
- 2006-01-25 WO PCT/US2006/002875 patent/WO2006081392A1/en not_active Ceased
- 2006-01-25 CN CNA2006800070563A patent/CN101132785A/zh active Pending
-
2007
- 2007-07-23 IL IL184771A patent/IL184771A/en active IP Right Grant
- 2007-08-01 ZA ZA2007/06402A patent/ZA200706402B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2595889C (en) | N-halogenated amino acids and n,n-dihalogenated amino acids in combination with hypohalous acids | |
| US7893109B2 (en) | N,N-dihalogenated amino acids and derivatives | |
| JOP20220069A1 (ar) | عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها | |
| JP5564264B2 (ja) | Ｎ−ハロゲン化アミノ化合物および誘導体 | |
| CN105407729A (zh) | 包含聚胺的组合物和方法 | |
| WO2021066080A1 (ja) | 薬剤、薬剤の製造方法、および、水の浄化方法 | |
| BRPI0407368A (pt) | tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas. | |
| WO2008028805A3 (de) | Verwendung einer pharmazeutischen zusammensetzung enthaltend ein anticholinergikum zur abtötung von mikroorganismen und zur behandlung von atemwegsinfektionen | |
| JP6269946B2 (ja) | 細菌の増殖抑制 | |
| RU2008128350A (ru) | Производные дифенилмочевины | |
| JP2025531846A (ja) | 抗菌組成物 | |
| HK1117748A (en) | N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids | |
| HK1103713B (en) | N,n-dihalogenated amino acids and derivatives |